Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterials - Protez Pharmaceuticals

Next Previous
Drug Profile

Research programme: antibacterials - Protez Pharmaceuticals

Alternative Names: Antibacterials for slow-growing and biofilm bacteria - Protez Pharmaceuticals; Bacteriocidal potentiators research programme - Protez Pharmaceuticals; Efflux pump inhibitors research programme - Protez Pharmaceuticals; INF 401; INF-271,468; Research programme: bacteriocidal potentiators - Protez Pharmaceuticals; Research programme: efflux pump inhibitors - Protez Pharmaceuticals

Latest Information Update: 06 Jun 2008

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Protez Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Gram-positive infections

Most Recent Events

  • 06 Jun 2008 Discontinued - Preclinical for Gram-positive infections in USA (unspecified route)
  • 23 Sep 2005 This programme is still in active development - BIO-2005 Annual International Convention (BIO-2005)
  • 02 Mar 2004 Influx has been acquired by, and merged into, Protez Pharmaceuticals

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top